Medios AG (FRA:ILM1)

Market Cap	304.03M
Revenue (ttm)	1.88B
Net Income (ttm)	12.55M
Shares Out	n/a
EPS (ttm)	0.51
PE Ratio	24.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	483
Open	11.78
Previous Close	11.62
Day's Range	11.78 - 11.78
52-Week Range	10.32 - 18.52
Beta	n/a
RSI	50.91
Earnings Date	May 13, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2016
• Employees: 952
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.